AR110378A1 - Métodos para determinar el estado del cáncer colorrectal en una persona - Google Patents

Métodos para determinar el estado del cáncer colorrectal en una persona

Info

Publication number
AR110378A1
AR110378A1 ARP170103522A ARP170103522A AR110378A1 AR 110378 A1 AR110378 A1 AR 110378A1 AR P170103522 A ARP170103522 A AR P170103522A AR P170103522 A ARP170103522 A AR P170103522A AR 110378 A1 AR110378 A1 AR 110378A1
Authority
AR
Argentina
Prior art keywords
person
methods
state
cancer
colorrectal
Prior art date
Application number
ARP170103522A
Other languages
English (en)
Inventor
Katryna Cisek
Ian Jeffery
Fergus Shanahan
Burkhardt Flemer
Paul Otoole
Original Assignee
Univ College Cork National Univ Of Ireland Cork
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ College Cork National Univ Of Ireland Cork filed Critical Univ College Cork National Univ Of Ireland Cork
Publication of AR110378A1 publication Critical patent/AR110378A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Un método para determinar el estado del cáncer colorrectal en una persona, que comprende perfilar la abundancia del microbioma de la persona.
ARP170103522A 2016-12-15 2017-12-14 Métodos para determinar el estado del cáncer colorrectal en una persona AR110378A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16204532 2016-12-15

Publications (1)

Publication Number Publication Date
AR110378A1 true AR110378A1 (es) 2019-03-20

Family

ID=57714386

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170103522A AR110378A1 (es) 2016-12-15 2017-12-14 Métodos para determinar el estado del cáncer colorrectal en una persona

Country Status (12)

Country Link
US (1) US11061029B2 (es)
EP (1) EP3555307A1 (es)
JP (1) JP2020516231A (es)
KR (1) KR20190117486A (es)
CN (1) CN110291211A (es)
AR (1) AR110378A1 (es)
AU (1) AU2017375040A1 (es)
CA (1) CA3047060A1 (es)
IL (1) IL267315A (es)
MA (1) MA51592A (es)
TW (1) TW201833330A (es)
WO (1) WO2018109219A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3118304A1 (en) * 2018-11-02 2020-05-07 The Regents Of The University Of California Methods to diagnose and treat cancer using non-human nucleic acids
TWI723312B (zh) * 2018-12-28 2021-04-01 中國醫藥大學附設醫院 電腦輔助直腸癌治療反應預測系統、方法及電腦程式產品
CN112080565A (zh) * 2019-06-14 2020-12-15 韩书文 结直肠癌的相关预测***、电子设备和存储介质
CN110512015A (zh) * 2019-09-11 2019-11-29 苏州普瑞森基因科技有限公司 一种肠癌生物标志物组合物及其应用
CN117305487A (zh) * 2020-05-27 2023-12-29 微度(苏州)生物科技有限公司 一种用于结直肠癌早期诊断的生物标志物组合物及应用
KR102623834B1 (ko) * 2020-07-13 2024-01-12 서울대학교병원 에스트로겐을 포함하는 장내 미생물총 변화를 통한 남성의 대장암 예방 또는 치료용 조성물
US20240069022A1 (en) * 2021-01-15 2024-02-29 Asahi Kasei Kabushiki Kaisha Method and kit for detecting presence and/or amount of bacteria of enterobacteriaceae in food/drink sample, environmental sample, or biological sample

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003287564A1 (en) * 2002-11-04 2004-06-07 Howard Hughes Medical Institute Methods of detecting colorectal cancer
US11060148B2 (en) * 2012-10-16 2021-07-13 Dana-Farber Cancer Institute, Inc. Diagnosing and treating colorectal cancer
WO2015018308A1 (en) * 2013-08-06 2015-02-12 BGI Shenzhen Co.,Limited Biomarkers for colorectal cancer
CN105473738B (zh) * 2013-08-06 2018-09-21 深圳华大基因科技有限公司 结直肠癌生物标志物
EP2955232B1 (en) 2014-06-12 2017-08-23 Peer Bork Method for diagnosing adenomas and/or colorectal cancer (CRC) based on analyzing the gut microbiome

Also Published As

Publication number Publication date
US11061029B2 (en) 2021-07-13
MA51592A (fr) 2021-03-17
CA3047060A1 (en) 2018-06-21
CN110291211A (zh) 2019-09-27
TW201833330A (zh) 2018-09-16
WO2018109219A1 (en) 2018-06-21
EP3555307A1 (en) 2019-10-23
IL267315A (en) 2019-08-29
AU2017375040A1 (en) 2019-06-27
JP2020516231A (ja) 2020-06-11
KR20190117486A (ko) 2019-10-16
US20200041510A1 (en) 2020-02-06

Similar Documents

Publication Publication Date Title
AR110378A1 (es) Métodos para determinar el estado del cáncer colorrectal en una persona
SA518390949B1 (ar) طريقة لتحديد المسامية المرتبطة بمادة عضوية في بئر أو تكوين
AR100498A1 (es) Mejora en la reducción de la fricción
PH12016501763A1 (en) Multispecific antibodies
CO2017005784A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
AR099564A1 (es) Composiciones fraguables y sus usos
ES2897914T8 (es) Compuestos que contienen nitrógeno, adecuados para el uso en la producción de poliuretanos
EA201790380A1 (ru) Ингибиторы mk2 и их применения
MX2016012285A (es) Tratamiento de cáncer con antagonista de c-met y correlación de estos con la expresión de hgf.
CL2016002419A1 (es) Métodos para determinar la probabilidad de padecer cáncer de próstata que comprende inmunoensayos de antígenos específicos de próstata
AR107786A1 (es) Métodos y composiciones para la detección y el diagnóstico de enfermedad renal y enfermedad periodontal
CL2019001522A1 (es) Oligonucleótidos modificados para el tratamiento de una enfermedad poliquística renal.
BR112017022022A2 (pt) arenavírus para uso no tratamento e/ou prevenção de tumores e método para a produção de arenavírus com propriedades de regressão de tumor (aprimoradas)
DK3402782T3 (da) 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decanderivater
MX2018002416A (es) Derivados de 1,7-diaril-1,6-heptadien-3,5-diona, procedimiento para la preparación y uso de los mismos.
AR110404A1 (es) MÉTODOS PARA EL TRATAMIENTO DE ENFERMEDADES FIBRÓTICAS UTILIZANDO EL INTERFERÓN-l
CL2019001526A1 (es) Métodos para el tratamiento de la enfermedad renal poliquística.
SV2017005403A (es) Formulación que comprende glicopirrolato, método y aparato
UY4314Q (es) Configuracion aplicada en zapato
WO2018083523A8 (en) Nanofluidic platform
CO2020008319A2 (es) Métodos para tratar la enfermedad de gaucher
GB2543709A (en) Pharmaceutical agent
GB201713512D0 (en) Apparatus and method for projecting and detecting light on a 2D or 3D surface, e.g. for semantic lighting based therapy
EA201891719A1 (ru) Светостойкий экстракт хмеля
AR102668A1 (es) Tratamiento de pozos

Legal Events

Date Code Title Description
FB Suspension of granting procedure